Table 4 Characteristics of each group according to the management of anticoagulants
| HBTa (n = 14) | Continuous use of warfarin (n = 10) | One-day skip of DOAC (n = 28) | Control (n = 643) | |
|---|---|---|---|---|
| Age, mean ± SD, years | 61 ± 17.6 | 71.3 ± 11.5 | 69.6 ± 7.1 | 64.5 ± 11.0 |
| Males/ Females, n | 11/ 3 | 7/ 3 | 21/ 7 | 370/ 273 |
| Using antiplatelets, n (%) | 4 (28.6) | 3 (30.0) | 6 (21.4) | 0 |
| PT, mean ± SD, seconds | 14.8 ± 2.1 | 22.1 ± 4.4*, ** | 12.9 ± 0.74 | 12.6 ± 9.46 |
| APTT, mean ± SD, seconds | 33.4 ± 4.3* | 37.6 ± 3.7*, *** | 34.2 ± 4.4* | 29.4 ± 4.5 |
| Polyp, n | 31 | 16 | 62 | 1304 |
| Pedunculated, n (%) | 3 (9.7) | 1 (6.3) | 5 (8.1) | 18 (1.4) |
| Size, mean ± SD, mm | 10.4 ± 7.0 | 8.2 ± 6.2 | 8.9 ± 5.6 | 9.5 ± 5.9 |
| Prophylactic clip, n (%) | 21 (67.7) | 9 (56.3) | 34 (54.8) | 688 (52.8) |
| Procedure by expertb, n (%) | 10 (32.6) | 4 (25.0) | 10 (16.1) | 404 (31.0) |
